No matter the way it starts out, my shares would be available for purchase at no less than $20.00. That's peanuts at 100M shares to big pharma in a buyout for a future pandemic fighting vaccine much less a vaccine that holds promise with several cancer indications.
The biggest thing is soaking up the day trader shares without scaring the crap out of investors. Don't chance dropping below pricing thresholds to stay listed. Trust me when I say going from the NAZ to the OTC has not been pleasant. I sure don't want to do it again.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links